Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.59M Sell
37,289
-2,842
-7% -$127K 0.49% 72
2026
Q1
$1.93M Buy
40,131
+6,984
+21% +$326K 0.66% 55
2025
Q4
$1.61M Buy
33,147
+2,177
+7% +$108K 0.56% 66
2025
Q3
$1.46M Buy
30,970
+4,021
+15% +$194K 0.54% 67
2025
Q2
$1.3M Buy
26,949
+377
+1% +$19.3K 0.51% 70
2025
Q1
$1.47M Sell
26,572
-4,240
-14% -$230K 0.64% 55
2024
Q4
$1.49M Buy
30,812
+2,049
+7% +$104K 0.68% 57
2024
Q3
$1.66M Buy
28,763
+1,487
+5% +$80.3K 0.77% 47
2024
Q2
$1.32M Buy
27,276
+3,299
+14% +$159K 0.68% 53
2024
Q1
$1.17M Buy
23,977
+3,608
+18% +$176K 0.65% 57
2023
Q4
$1.01M Buy
20,369
+7,803
+62% +$382K 0.65% 56
2023
Q3
$684K Buy
12,566
+1,043
+9% +$55.6K 0.51% 70
2023
Q2
$621K Buy
11,523
+349
+3% +$18.8K 0.49% 71
2023
Q1
$608K Buy
11,174
+1,235
+12% +$60.1K 0.54% 67
2022
Q4
$481K Buy
+9,939
New +$436K 0.49% 73

Other funds holding SNY

HF Advisory Group's SNY Position: Q2 2026 in Review

HF Advisory Group reduced its Sanofi (SNY) stake by 7.1% in Q2 2026, selling an estimated $127K and leaving 37,289 shares worth $1.59M. The position accounts for 0.49% of the portfolio, ranked #72.

HF Advisory Group first reported a position in SNY in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.93M in Q1 2026. 97 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • HF Advisory Group held 37,289 shares of Sanofi worth $1.59M as of Q2 2026.
  • HF Advisory Group sold 2,842 Sanofi shares in Q2 2026, an estimated $127K.
  • Sanofi made up 0.49% of HF Advisory Group's portfolio in Q2 2026, its #72 holding.
  • HF Advisory Group first reported a position in Sanofi in Q4 2022 and has held it in 15 quarters since.
  • HF Advisory Group's Sanofi position peaked at $1.93M in Q1 2026.
  • 97 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on HF Advisory Group's 13F filing for Q2 2026, filed 9 Jul 2026.